v3.25.3
Segment and corporate information (Details) - EUR (€)
€ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Segment and corporate information          
Revenue from contracts with customers € 4,296,863 € 4,314,510 € 12,936,065 € 12,987,628  
Revenue from insurance contracts 567,578 429,946 1,559,217 1,205,997  
Revenue from lease contracts 20,409 15,706 62,735 57,497  
Revenue 4,884,850 4,760,162 14,558,017 14,251,122  
Costs of revenue (3,642,632) (3,614,078) (10,917,460) (10,764,898)  
Research and development (37,748) (40,047) (119,346) (133,433)  
Operating income (loss) 476,505 462,696 1,233,178 1,133,498  
Interest (73,937) (82,170) (229,403) (255,688)  
Income before income taxes 402,568 380,526 1,003,775 877,810  
Depreciation and amortization (358,214) (372,093) (1,102,842) (1,143,590)  
Impairment loss 957 6,299 (24,013) (121,666)  
Income (loss) from equity method investees 46,672 41,248 139,680 102,730  
Total assets 30,887,005 32,510,801 30,887,005 32,510,801 € 33,566,579
thereof investment in equity method investees 751,181 690,794 751,181 690,794 € 620,831
Additions of property, plant and equipment, intangible assets and right-of-use assets 279,452 331,332 884,154 916,982  
Healthcare services          
Segment and corporate information          
Revenue from contracts with customers 3,219,669 3,292,628 9,721,334 9,986,979  
Revenue 3,219,669 3,292,628 9,721,334 9,986,979  
Healthcare products          
Segment and corporate information          
Revenue from contracts with customers 1,077,194 1,021,882 3,214,731 3,000,649  
Revenue from lease contracts 20,409 15,706 62,735 57,497  
Revenue 1,097,603 1,037,588 3,277,466 3,058,146  
Total Segment          
Segment and corporate information          
Revenue from contracts with customers 4,296,863 4,314,510 12,936,065 12,987,628  
Revenue from insurance contracts 567,578 429,946 1,559,217 1,205,997  
Revenue from lease contracts 20,409 15,706 62,735 57,497  
Revenue 4,884,850 4,760,162 14,558,017 14,251,122  
Total Segment | Healthcare services          
Segment and corporate information          
Revenue from contracts with customers 3,219,669 3,292,628 9,721,334 9,986,979  
Total Segment | Healthcare products          
Segment and corporate information          
Revenue from contracts with customers 1,077,194 1,021,882 3,214,731 3,000,649  
Care Delivery          
Segment and corporate information          
Revenue from contracts with customers 3,273,241 3,339,833 9,863,792 10,061,186  
Revenue 3,273,241 3,339,833 9,863,792 10,061,186  
Care Delivery | Healthcare services          
Segment and corporate information          
Revenue from contracts with customers 3,211,730 3,291,969 9,669,848 9,924,270  
Care Delivery | Healthcare products          
Segment and corporate information          
Revenue from contracts with customers 61,511 47,864 193,944 136,916  
Value-Based Care          
Segment and corporate information          
Revenue from contracts with customers 7,939 659 51,486 62,709  
Revenue from insurance contracts 567,578 429,946 1,559,217 1,205,997  
Revenue 575,517 430,605 1,610,703 1,268,706  
Value-Based Care | Healthcare services          
Segment and corporate information          
Revenue from contracts with customers 7,939 659 51,486 62,709  
Care Enablement          
Segment and corporate information          
Revenue from contracts with customers 1,015,683 974,018 3,020,787 2,863,733  
Revenue from lease contracts 20,409 15,706 62,735 57,497  
Revenue 1,036,092 989,724 3,083,522 2,921,230  
Care Enablement | Healthcare products          
Segment and corporate information          
Revenue from contracts with customers 1,015,683 974,018 3,020,787 2,863,733  
Operating Segments | Total Segment          
Segment and corporate information          
Revenue 5,337,883 5,260,873 15,915,355 15,721,064  
Costs of revenue (4,086,886) (4,110,019) (12,254,410) (12,214,132)  
Research and development (37,954) (39,977) (119,552) (133,363)  
Operating income (loss) 484,166 480,249 1,328,296 1,133,075  
Depreciation and amortization (352,003) (365,319) (1,082,875) (1,122,294)  
Impairment loss 941 6,299 (24,029) (121,666)  
Income (loss) from equity method investees 46,672 41,248 139,680 102,730  
Total assets 55,535,068 58,798,600 55,535,068 58,798,600  
thereof investment in equity method investees 751,181 690,794 751,181 690,794  
Additions of property, plant and equipment, intangible assets and right-of-use assets 275,252 334,262 888,758 921,234  
Operating Segments | Care Delivery          
Segment and corporate information          
Revenue 3,401,706 3,470,861 10,229,217 10,432,522  
Costs of revenue (2,564,750) (2,695,842) (7,907,680) (8,159,146)  
Research and development   41   19  
Operating income (loss) 419,474 456,012 1,085,873 958,104  
Depreciation and amortization (235,080) (253,222) (739,402) (778,222)  
Impairment loss (257) 7,712 (17,336) (104,537)  
Income (loss) from equity method investees 46,672 41,248 139,680 102,730  
Total assets 40,572,794 42,680,707 40,572,794 42,680,707  
thereof investment in equity method investees 751,181 690,794 751,181 690,794  
Additions of property, plant and equipment, intangible assets and right-of-use assets 143,797 215,899 531,282 621,880  
Operating Segments | Value-Based Care          
Segment and corporate information          
Revenue 575,517 430,605 1,610,703 1,268,706  
Costs of revenue (579,371) (449,134) (1,558,685) (1,221,716)  
Operating income (loss) (21,960) (36,565) (27,553) (21,325)  
Depreciation and amortization (1,354) (1,082) (4,030) (3,336)  
Impairment loss 21   (2,171)    
Total assets 584,495 616,068 584,495 616,068  
Additions of property, plant and equipment, intangible assets and right-of-use assets 117 97 315 451  
Operating Segments | Care Enablement          
Segment and corporate information          
Revenue 1,360,660 1,359,407 4,075,435 4,019,836  
Costs of revenue (942,765) (965,043) (2,788,045) (2,833,270)  
Research and development (37,954) (40,018) (119,552) (133,382)  
Operating income (loss) 86,652 60,802 269,976 196,296  
Depreciation and amortization (115,569) (111,015) (339,443) (340,736)  
Impairment loss 1,177 (1,413) (4,522) (17,129)  
Total assets 14,377,779 15,501,825 14,377,779 15,501,825  
Additions of property, plant and equipment, intangible assets and right-of-use assets 131,338 118,266 357,161 298,903  
Operating Segments | Corporate          
Segment and corporate information          
Costs of revenue (4,333) 23 (2,243) (4,898)  
Research and development 206 (70) 206 (70)  
Operating income (loss) (4,207) (13,348) (77,965) 9,103  
Depreciation and amortization (16,569) (17,561) (50,567) (53,582)  
Impairment loss 16   16    
Total assets 11,344,082 11,027,934 11,344,082 11,027,934  
Additions of property, plant and equipment, intangible assets and right-of-use assets 14,763 9,133 26,738 35,260  
Inter-segment          
Segment and corporate information          
Revenue (453,033) (500,711) (1,357,338) (1,469,942)  
Costs of revenue 448,587 495,918 1,339,193 1,454,132  
Operating income (loss) (3,454) (4,205) (17,153) (8,680)  
Depreciation and amortization 10,358 10,787 30,600 32,286  
Total assets (35,992,145) (37,315,733) (35,992,145) (37,315,733)  
Additions of property, plant and equipment, intangible assets and right-of-use assets (10,563) (12,063) (31,342) (39,512)  
Inter-segment | Total Segment          
Segment and corporate information          
Revenue (453,033) (500,711) (1,357,338) (1,469,942)  
Inter-segment | Care Delivery          
Segment and corporate information          
Revenue (128,465) (131,028) (365,425) (371,336)  
Inter-segment | Care Enablement          
Segment and corporate information          
Revenue € (324,568) € (369,683) € (991,913) € (1,098,606)